Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Sanford-Burnham, with operations in California and Florida, is one of the fastest-growing research institutes in the country.
The Institute ranks among the top 4 institutions nationally for NIH grant funding. For the past decade (1999-2009), Sanford-Burnham ranked #1 worldwide in the fields of biology and biochemistry for the impact of its research publications (defined by citations per publication), according to the Institute for Scientific Information.
Sanford-Burnham utilizes a unique, collaborative approach to medical research and has established major research programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory, and childhood diseases. The Institute is especially known for its world-class capabilities in stem cell research and drug discovery technologies.
In September 2008, Sanford-Burnham was awarded a $98 million grant by the NIH to establish the Conrad Prebys Center for Chemical Genomics. The Center has capabilities more commonly found in large pharmaceutical companies when it comes to taking basic research and translating it into compounds that could become the prototype medicines of tomorrow.